Hypnosis vs Midazolam for Sedation for TEE
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01749475|
Recruitment Status : Completed
First Posted : December 13, 2012
Last Update Posted : March 1, 2013
|Condition or disease||Intervention/treatment|
|Clinical Indications for Transesophageal Echocardiography||Drug: Midazolam Other: hypnotherapy|
|Study Type :||Observational|
|Actual Enrollment :||98 participants|
|Official Title:||Hypnosis for Sedation in Transesophageal Echocardiography: Comparison With Midazolam|
|Study Start Date :||June 2010|
|Actual Primary Completion Date :||August 2010|
|Actual Study Completion Date :||September 2010|
The patients will be given 0.05mg/kg iv midazolam just before monitorization. During probing, in case of intolerance to the insertion of the probe, the increments of midazolam with 0.005mg/kg doses will be given.
A first hypnotic induction will be carried out the day before the procedure, next day, fifteen minutes before the procedure, a new induction will be performed.
- Sedative effects of hypnotherapy and the drug "midazolam" indicated by anxiety scores and bispectral index (BIS) monitoring [ Time Frame: during transesophageal echocardiography ]
- measurement of alertness after sedation with continuous performance test (CPT) [ Time Frame: the same time frame ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01749475
|Bakirkoy Dr Sadi Konuk Training Hospital|